U.S. federal trademark · Serial No. 99668592
Formulation of pharmaceuticals, namely, pharmaceutical compounding for inflammatory and respiratory diseases; pharmaceutical formulation, namely, pharmaceutical compounding services in the field of inflammatory and respiratory diseases
Pharmaceutical preparations and drugs for the treatment, control, prevention, maintenance, and management of inflammatory and respiratory diseases and symptoms in humans; anti-inflammatory and immunomodulatory pharmaceutical compositions; medications for respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), bronchitis, cystic fibrosis, pneumonia, allergic rhinitis, Idiopathic Pulmonary Fibrosis (IPF), bronchiectasis, chronic cough and other pulmonary disorders; pharmaceutical compositions in the form of tablets, capsules, liquids, aerosols, inhalers, creams, ointments, gels, and injectables for the treatment of inflammatory and respiratory diseases and symptoms in humans; fixed-dose combination pharmaceutical preparations for inflammatory and respiratory diseases and symptoms in humans; combination pharmaceutical preparations comprising two or more active ingredients for inflammatory and respiratory diseases and symptoms in humans; pharmaceutical preparations for use in combination therapy for inflammatory and respiratory diseases and symptoms in humans
Research, development, and formulation being research and development of pharmaceuticals for inflammatory and respiratory diseases; pharmaceutical formulation in the nature of pharmaceutical research and development services in the field of inflammatory and respiratory diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.